"Pyrroles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.
Descriptor ID |
D011758
|
MeSH Number(s) |
D03.383.129.578
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pyrroles".
Below are MeSH descriptors whose meaning is more specific than "Pyrroles".
This graph shows the total number of publications written about "Pyrroles" by people in this website by year, and whether "Pyrroles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
1998 | 0 | 1 | 1 |
2000 | 0 | 2 | 2 |
2001 | 0 | 1 | 1 |
2002 | 1 | 3 | 4 |
2003 | 15 | 3 | 18 |
2004 | 9 | 3 | 12 |
2005 | 10 | 1 | 11 |
2006 | 12 | 3 | 15 |
2007 | 11 | 3 | 14 |
2008 | 19 | 10 | 29 |
2009 | 8 | 7 | 15 |
2010 | 13 | 9 | 22 |
2011 | 18 | 16 | 34 |
2012 | 16 | 6 | 22 |
2013 | 16 | 7 | 23 |
2014 | 10 | 10 | 20 |
2015 | 11 | 2 | 13 |
2016 | 6 | 6 | 12 |
2017 | 8 | 3 | 11 |
2018 | 3 | 4 | 7 |
2019 | 2 | 5 | 7 |
2020 | 2 | 3 | 5 |
2021 | 8 | 5 | 13 |
2022 | 1 | 6 | 7 |
2023 | 0 | 2 | 2 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pyrroles" by people in Profiles.
-
Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis. Endocrinology. 2024 Feb 20; 165(4).
-
KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatr Blood Cancer. 2024 Apr; 71(4):e30898.
-
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Sci Rep. 2023 11 18; 13(1):20223.
-
Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evid. 2023 Jun; 2(6):EVIDoa2200339.
-
Quality of Studies for Gastric pH Measurements With Vonoprazan. Am J Gastroenterol. 2022 11 01; 117(11):1882.
-
Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors. J Biol Chem. 2022 08; 298(8):102226.
-
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine. Leuk Res. 2022 08; 119:106884.
-
Recent Advances in Designing Electroconductive Biomaterials for Cardiac Tissue Engineering. Adv Healthc Mater. 2022 07; 11(13):e2200055.
-
Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1N546K Mutation. JCO Precis Oncol. 2022 04; 6:e2100371.
-
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study. J Immunother Cancer. 2022 03; 10(3).